Octagam (intravenous normal human immunoglobulin) / Octapharma  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Octagam (intravenous normal human immunoglobulin) / Octapharma
2011-001982-42: A study of the effect of antiretroviral therapy and immunoglobulin on the HIV reservoir in Acute HIV Infection.

Ongoing
4
10
Europe
Octagam, Solution for infusion, Octagam
Guy's & St. Thomas' NHS Foundation Trust, Guy's & St. Thomas' Charity
Acute HIV Infection, Acute HIV Infection, Diseases [C] - Immune System Diseases [C20]
 
 
NCT03348618: A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)

Unknown status
4
21
US
IVIG, Octagam 5%
IMMUNOe Research Centers, Octapharma
Pediatric Acute-Onset Neuropsychiatric Syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
11/19
03/20
NCT04411667: Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19

Completed
4
34
US
Octagam, IVIG
George Sakoulas, MD, Octapharma
Sars-CoV2
06/20
06/20
NCT04616001: IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation

Not yet recruiting
4
10
US
IVIG, Octagam
Sharp HealthCare
Covid19, SARS-CoV Infection
06/21
06/21

Download Options